Physician profile
Taral Patel
NPI 1780632828
$888,087.28
in general payments reported to CMS, 2019-2025
100 companies · $163K in 2025
The $163K reported for 2025 was more than what 99% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74K · 2020: $83K · 2021: $69K · 2022: $170K · 2023: $184K · 2024: $145K · 2025: $163K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $171K · Consulting Fee: $128K · Honoraria: $107K · Travel and Lodging: $58K · Food and Beverage: $29K · Education: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $170,625.25 |
| Consulting Fee | $127,911.00 |
| Honoraria | $106,541.75 |
| Travel and Lodging | $57,960.05 |
| Food and Beverage | $28,769.31 |
| Education | $267.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karyopharm Therapeutics INC. | $185,014.05 | 2020-2025 | Xpovio |
| Daiichi Sankyo INC. | $116,316.43 | 2020-2025 | Enhertu, Datroway |
| Glaxosmithkline, LLC. | $64,360.56 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Incyte Corporation | $61,319.74 | 2020-2025 | Jakafi, Monjuvi, Pemazyre |
| Janssen Biotech, INC. | $54,320.26 | 2019-2025 | Carvykti, Darzalex, Tecvayli |
| Beigene USA, INC. | $37,516.39 | 2020-2025 | Brukinsa |
| E.R. Squibb & Sons, L.L.C. | $32,223.45 | 2019-2025 | Opdivo, Opdualag |
| Emd Serono, INC. | $27,427.97 | 2019-2025 | Tepmetko, Bavencio |
| Pharmacosmos Therapeutics INC. | $20,702.43 | 2023-2025 | Monoferric, Cosela |
| Genentech USA, INC. | $19,363.61 | 2019-2025 | Polivy, Lunsumio, Columvi |
| Pfizer INC. | $19,153.03 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17,676.90 | 2019-2025 | Ninlaro, Fruzaqla, Alunbrig |
| Genzyme Corporation | $15,743.21 | 2019-2025 | |
| Gilead Sciences, INC. | $15,635.33 | 2021-2025 | Trodelvy |
| Merck Sharp & Dohme LLC | $15,233.17 | 2019-2025 | Keytruda, Lynparza, Welireg |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $14,725.24 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Mirati Therapeutics, INC. | $14,712.13 | 2023-2024 | Krazati |
| Astrazeneca Pharmaceuticals LP | $14,172.51 | 2020-2025 | Lynparza, Imfinzi, Enhertu |
| Bayer Healthcare Pharmaceuticals INC. | $12,218.00 | 2019-2023 | |
| Apellis Pharmaceuticals, INC. | $9,894.61 | 2022-2023 | Empaveli, Empaveli |
| Beone Medicines USA, INC. | $9,655.36 | 2025 | Brukinsa, Tevimbra |
| Seagen INC. | $9,600.43 | 2019-2023 | Padcev, Tukysa, Adcetris |
| Verastem, INC. | $9,463.13 | 2019-2020 | |
| Astellas Pharma US INC | $9,220.56 | 2021-2025 | Vyloy, Padcev, Xtandi |
| Kite Pharma, INC. | $6,130.74 | 2022-2025 | Yescarta |
| Avyxa Pharma, LLC | $5,858.00 | 2025 | |
| Epizyme, INC. | $5,441.55 | 2020-2021 | |
| Cti Biopharma Corp. | $5,262.00 | 2022-2023 | Vonjo |
| Lilly USA, LLC | $5,174.63 | 2021-2025 | Retevmo, Verzenio, Jaypirca |
| Jazz Pharmaceuticals INC. | $5,124.21 | 2019-2025 | Zepzelca |
| Janssen Scientific Affairs, LLC | $4,867.19 | 2022-2025 | Tecvayli, Darzalex, Erleada |
| Blueprint Medicines Corporation | $4,344.49 | 2020-2025 | Ayvakit |
| Johnson & Johnson Health Care Systems INC. | $3,614.57 | 2023-2025 | Carvykti, Darzalex, Tecvayli |
| Genmab U.S., INC. | $3,510.43 | 2023-2025 | Epkinly, Tivdak |
| Eisai INC. | $2,475.91 | 2020-2025 | |
| Fresenius Kabi USA, LLC | $2,425.00 | 2021-2023 | Stimufend |
| Sanofi US Services INC. | $2,332.00 | 2025 | |
| Pfizer International LLC | $2,044.35 | 2019 | |
| Intrinsiq Specialty Solutions, INC. | $1,850.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $1,769.18 | 2022-2025 | Libtayo, Lynozyfic |
| Janssen Pharmaceuticals, INC | $1,760.00 | 2025 | |
| Celgene Corporation | $1,754.89 | 2019-2025 | Reblozyl, Opdivo, Opdualag |
| Taiho Oncology, INC. | $1,462.26 | 2020-2025 | |
| Adaptive Biotechnologies Corporation | $1,276.93 | 2020-2024 | Clonoseq |
| Aveo Pharmaceuticals, INC. | $1,186.90 | 2021-2025 | Fotivda |
| Puma Biotechnology, INC. | $1,144.49 | 2020-2023 | |
| Caris Mpi, INC. | $1,110.55 | 2025 | Mi Cancer Seek |
| Spectrum Pharmaceuticals INC. | $1,008.62 | 2023-2025 | Rolvedon |
| Tersera Therapeutics LLC | $924.25 | 2020-2025 | Zoladex, Xermelo |
| Novartis Pharmaceuticals Corporation | $791.02 | 2019-2025 | |
| Acceleron Pharma, INC. | $666.27 | 2021 | |
| Deciphera Pharmaceuticals INC. | $539.65 | 2021-2022 | |
| Tg Therapeutics, INC. | $450.00 | 2021 | |
| Heron Therapeutics, INC. | $395.11 | 2023 | Sustol |
| Asd Specialty Healthcare, LLC | $365.18 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $329.32 | 2019-2025 | Tazverik, Onivyde, Somatuline Depot |
| Sanofi-Aventis U.S. LLC | $269.34 | 2022 | |
| Abbvie INC. | $266.51 | 2019-2025 | |
| Array Biopharma INC | $258.26 | 2022-2025 | Mektovi, Braftovi, Lorbrena |
| Sobi, INC | $253.64 | 2023-2025 | |
| Exelixis INC. | $241.69 | 2019-2025 | Cabometyx |
| Amgen INC. | $241.64 | 2019-2024 | Kyprolis, Lumakras |
| Alexion Pharmaceuticals, INC. | $237.53 | 2019-2024 | Ultomiris |
| Fennec Pharmaceuticals, INC. | $228.47 | 2024 | Pedmark |
| Pharmacyclics LLC, An Abbvie Company | $206.88 | 2022-2023 | Imbruvica, Epkinly |
| Genentech, INC. | $204.26 | 2019 | |
| Stemline Therapeutics INC. | $195.98 | 2023-2025 | Orserdu, Elzonris |
| G1 Therapeutics, INC. | $180.02 | 2022-2023 | Cosela |
| Pharmaessentia USA Corporation | $174.10 | 2023-2025 | Besremi |
| Sirtex Medical INC | $142.40 | 2022 | |
| Tesaro, INC. | $136.46 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $129.37 | 2022 | |
| Myovant Sciences INC. | $123.39 | 2022 | |
| Tempus Ai, INC | $122.72 | 2025 | Xt Cdx |
| Agios Pharmaceuticals, INC. | $115.20 | 2019-2025 | Pyrukynd |
| Geron Corporation | $113.54 | 2024-2025 | Rytelo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.54 | 2021-2023 | Gilotrif |
| Servier Pharmaceuticals LLC | $97.17 | 2022-2024 | |
| Legend Biotech USA INC. | $88.18 | 2025 | Carvykti |
| Coherus Oncology, INC. | $83.33 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $73.41 | 2019-2020 | |
| Springworks Therapeutics, INC. | $66.00 | 2024-2025 | Ogsiveo, Gomekli |
| Dendreon Pharmaceuticals LLC | $58.19 | 2020-2023 | Provenge |
| Adc Therapeutics America, INC. | $58.09 | 2022-2024 | |
| Amneal Pharmaceuticals LLC | $54.12 | 2023-2024 | Avastin, Neulasta, Neupogen |
| Syndax Pharmaceuticals, INC. | $50.23 | 2025 | |
| Sun Pharmaceutical Industries INC. | $44.99 | 2022-2023 | Yonsa, Odomzo |
| Accord Healthcare, INC. | $43.42 | 2025 | |
| Foundation Medicine, INC. | $40.74 | 2020-2023 | |
| Amag Pharmaceuticals, INC. | $38.88 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $31.01 | 2023-2024 | Orgovyx |
| Morphosys, US INC. | $30.58 | 2023 | Monjuvi |
| Ge Healthcare | $25.38 | 2025 | |
| Octapharma USA, INC. | $24.74 | 2025 | Octagam Immune Globulin (Human) |
| Dova Pharmaceuticals | $24.02 | 2020-2021 | |
| Progenics Pharmaceuticals, INC. | $22.36 | 2025 | |
| Eli Lilly and Company | $21.04 | 2024 | Retevmo |
| Acrotech Biopharma INC. | $16.89 | 2021 | |
| Immunocore Limited | $15.83 | 2025 | Kimmtrak |
| Tolmar Pharmaceuticals, INC. | $15.33 | 2019 |
Drugs and devices associated with these payments
Xpovio $121KBrukinsa $42KCarvykti $34KEnhertu $33KOjjaara $31KDarzalex $28KTecvayli $23KOpdivo $21KMonoferric $20KJakafi $20KRybrevant $18KKrazati $15KTrodelvy $13KPolivy $12KLunsumio $12KColumvi $12KEmpaveli $9,492Tecentriq $6,959Sarclisa $3,652Epkinly $3,652Lorbrena $3,586Ibrance $3,364Lynparza $3,105Ayvakit $2,472Padcev $2,178Imfinzi $1,551Rezlidhia $1,380Tavalisse $1,380Mi Cancer Seek $1,111Tepmetko $1,041Rolvedon $1,009Datroway $838Talvey $777Erleada $526Monjuvi $514Keytruda $446Libtayo $425Cosela $400Sustol $395Stimufend $370Retevmo $364Lenvima $335Imbruvica $326Pedmark $228Braftovi $205Mektovi $205Venclexta $203Pemazyre $202Zepzelca $191Cabometyx $190Clonoseq $188Orserdu $177Besremi $174Lutrate Depot $156Axtle $156Posfrea $156Frindovyx $156Docivyx $156Vonjo $155Kisqali $147Reblozyl $146Fotivda $137Verzenio $129Zirabev $128Tukysa $124Xt Cdx $123Xalkori $123Scemblix $120Rytelo $114Zoladex $107Jaypirca $106Lutathera $104Zynyz $99.53Xtandi $93.86Vyloy $92.97Tagrisso $88.49Pluvicto $88.21Gavreto $82.89Ninlaro $74.36Tazverik $73.59Fabhalta $71.97Procrit $69.86Tasigna $64.91Tevimbra $64.56Imjudo $63.72Bavencio $56.83Onivyde $55.76Avastin $54.12Zejula $51.13Jemperli $51.13Ogsiveo $48.11Welireg $46.07Yescarta $45.10Xermelo $45.05Inqovi $44.48Lonsurf $44.48Camcevi $43.42Tibsovo $41.58Inlyta $40.02Comirnaty $39.62
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taral Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.